|
May 3
|
Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates
|
|
Apr 27
|
CureVac Full Year 2023 Earnings: Misses Expectations
|
|
Apr 25
|
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
|
|
Apr 24
|
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
|
|
Apr 24
|
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
|
|
Apr 24
|
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
|
|
Apr 24
|
CureVac to cut costs in restructuring
|
|
Apr 23
|
CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%
|
|
Apr 18
|
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
|
|
Apr 16
|
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
|
|
Apr 4
|
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
|
|
Jan 5
|
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
|
|
Dec 30
|
13 Best Get Rich Quick Stocks To Buy
|
|
Dec 22
|
These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts
|
|
Dec 19
|
Rebel's Edge - December 19: $RUN, $AFRM, $CVAC, and College Football Recruits
|
|
Dec 19
|
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
|
|
Dec 19
|
CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
|
|
Dec 19
|
UPDATE 2-German court quashes CureVac patent after challenge by BioNTech
|
|
Dec 12
|
Are Investors Undervaluing CureVac N.V. (NASDAQ:CVAC) By 26%?
|
|
Aug 8
|
Further weakness as CureVac (NASDAQ:CVAC) drops 9.7% this week, taking one-year losses to 40%
|